Refine by
Blood Penetration Tester Equipment Supplied In France
7 equipment items found
Manufactured by:OncoDiag based inMiserey, FRANCE
An accurate blood-based test for the screening of colorectal cancer ...
Manufactured by:Owen Mumford Ltd. based inOxfordshire, UNITED KINGDOM
Empowering you to take control. Discrete testing from the comfort of your home. Simplitude ByMe is a rapid diagnostic test distributed by Owen Mumford, helping you to take control of monitoring your health from the comfort of your ...
Manufactured by:Precision For Medicine, Inc. based inFrederick, MARYLAND (USA)
PBMCs are a vital component to understanding human immune function and disease response. Variability in quality, availability, and purity can derail a research study. At Precision for Medicine, PBMCs are collected and processed within our FDA-registered facility to ensure optimal cell yields, viability, and quality. ...
Manufactured by:Endodiag based inParis, FRANCE
EndoDTectis a blood test based on the analysis of a combination of biomarkers. Changes in their expression levels indicate if a subject has endometriosis or not. Combining high sensitivity and specificity, EndoDTect has the potential to dramatically reduce diagnosis delays. Endodiag is currently conducting validation studies to confirm the predictive value of EndoDTect® for disease ...
Manufactured by:Bio-Rad Laboratories, Inc. based inHercules, CALIFORNIA (USA)
The BioPlex 2200 HIV Ag-Ab assay is a multiplex flow immunoassay intended for the simultaneous qualitative detection and differentiation of the individual analytes HIV-1 p24 antigen, HIV-1 (groups M and O) antibodies, and HIV-2 antibodies in human serum or plasma (fresh or frozen K2 EDTA, K3 EDTA, lithium heparin, sodium heparin; fresh citrate). This kit is intended as an aid in the diagnosis of ...
Manufactured by:Firalis Group based inHuningue, FRANCE
NEUROLINCS : A non-invasive in-vitro diagnostic test measuring 7494 brain-enriched long non-coding RNAs (lncRNAs) that are specific to neurodegenerative ...
Manufactured by:GENFIT based inLoos, FRANCE
Nonalcoholic steatohepatitis (NASH) remains largely underdiagnosed, as it carries no obvious symptoms in its early stages, and also because of the lack of widely available non-invasive tests specifically developed to diagnose the disease. The underdiagnosis of NASH represents a major unmet need, and is a barrier for identification of patients at higher risk for disease progression, who would be ...